Duran Niebuhr

Understanding Multiple Myeloma Class Action Lawsuits: Key Allegations, Current Status, and What Patients Should KnowMultiple myeloma, a complex cancer of plasma cells in the bone marrow, has actually seen significant treatment advances over the previous 20 years. Novel immunomodulatory drugs (IMiDs) like lenalidomide (Revlimid ®), pomalidomide (Pomalyst ®), and thalidomide (Thalomid ®), together

Multiple Myeloma Attorneys: How Legal Help Can Support Patients and Families A helpful guide for anybody impacted by multiple myeloma who is thinking about pursuing a legal claim. IntroMultiple myeloma is a malignant plasma‑cell disorder that accounts for approximately 1.8% of all cancer detects in the United States

Understanding the Landscape: Multiple Myeloma Lawsuits and Patient Safety ConcernsMultiple myeloma, a cancer of plasma cells in the bone marrow, stays a severe diagnosis, though developments in treatment have considerably improved survival rates over the past 2 decades. As novel therapies like immunomodulatory drugs (IMiDs), proteasome inhibitors, and monoclonal antibodies